A significant discovery in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in many forms of cancer, causing https://socialistener.com/story7411633/mini-antibodies-revive-tumor-suppressor-p53-a-potential-pathway-for-malignant-therapy